Hot Alert: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Recro Pharma, Inc. (NASDAQ:REPH), Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), Facebook Inc (NASDAQ:FB), Microsoft Corporation (NASDAQ:MSFT)

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on July 30, 2015, declared financial results for the second quarter of 2015. Net product sales of Soliris® (eculizumab) grew to $636 million, a 24% increase, compared to $512.5 million for the same period in 2014, despite currency headwinds. Non-GAAP diluted earnings per share (EPS) for the second quarter of 2015 were $1.44, compared to $1.12 in the second quarter of 2014. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) belongs to Healthcare sector. Its net profit margin is 24.60% and weekly performance is -4.80%. On last trading day company shares ended up $189.73. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) distance from 50-day simple moving average (SMA50) is 2.42%.

Recro Pharma, Inc. (NASDAQ:REPH) on 22 July, announced the appointment of Scott Rizzo as General Manager of the Company’s contract manufacturing facility located in Gainesville, Georgia. Recro Pharma, Inc. (NASDAQ:REPH) shares fell -5.92% in last trading session and ended the day at $12.39. REPH return on assets is -95.00%. Recro Pharma, Inc. (NASDAQ:REPH) quarterly performance is 44.57%.

Cowen and Business restated their hold rating on shares of Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) in a study released on Wednesday. On 06 August, Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) shares fell -4.50% and was closed at $22.08. MNTA EPS growth in last 5 year was -3.60%. Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) year to date (YTD) performance is 83.39%.

Facebook Inc (NASDAQ:FB) introduced a new feature on Aug. 5, wherein, businesses can communicate with their customers through private messages. On 06 August, Facebook Inc (NASDAQ:FB) shares fell -1.37% and was closed at $95.12. FB EPS growth in last 5 year was 78.90%. Facebook Inc (NASDAQ:FB) year to date (YTD) performance is 21.92%.

Microsoft Corp. (NASDAQ:MSFT) announced Wednesday that it will increase total paid leave for new mothers to 20 weeks, from a current 12 weeks paid and eight weeks of unpaid leave. Microsoft Corporation (NASDAQ:MSFT) now has updated its paid leave policy for new mothers and fathers. Microsoft Corporation (NASDAQ:MSFT) ended the last trading day at $46.62. Company weekly volatility is calculated as 2.04% and price to cash ratio as 3.91. Microsoft Corporation (NASDAQ:MSFT) showed a weekly performance of -0.55%.

Leave a Reply

Your email address will not be published. Required fields are marked *